The left-wing obsession with protecting feelings has reached absurd heights, manifesting in dangerous movements like “body ...

Radio Ink sat down with Cumulus Media/Westwood One Chief Insights Officer Pierre Bouvard to discuss the evolution of radio ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the ...

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

How has the relationship between Big Pharma and biotech evolved? And where do CROs fit into the mix? Dearth of VC funding forcing difficult biotech decisions The realities of the global economy ...